This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area
of etiopathogenesis, we now have a better understanding of the immune response that …

The treatment options for pulmonary sarcoidosis have increased over the past 10 years. As
new treatments have been introduced, the best way to assess and compare treatments …

This manuscript offers an approach to the treatment of pulmonary sarcoidosis based on
current available information. The treatment of pulmonary sarcoidosis is not mandatory as …

The clinical spectrum of sarcoidosis is protean, but pulmonary manifestations typically
dominate. Abnormalities are present on chest radiographs in 90% to 95% of patients …

Sarcoidosis is a multisystem disorder of unknown origin and poorly understood
pathogenesis that predominantly affects lungs and intrathoracic lymph nodes and is …

Sarcoidosis is an inflammatory granulomatous disease that is characterized by diverse
organ system manifestations, a variable clinical course, and a predilection for affecting …

Sarcoidosis can affect any organ in the body. Frequently extrapulmonary manifestations of
the disease are the major cause of morbidity. Treatment of extrapulmonary sarcoidosis often …

Sarcoidosis, a granulomatous disorder of unknown etiology, characteristically involves
multiple organs. However, pulmonary manifestations typically dominate. Chest radiographs …

Sarcoidosis is a systemic, clinically heterogeneous disease characterized by the
development of granulomas. Any organ system can be involved, and patients may present …

Pathologists are frequently involved in the diagnosis of sarcoidosis on conventional biopsies
or examining bronchoalveolar lavage fluid and assisting bronchoscopists when performing …